Preparation method of cefuroxime acid delta 3-isomer and cefuroxime axetil delta 3-isomer prepared by using same
By using silicification and hydrolysis reactions in cefuroxime synthesis, δ3-isomers of cefuroxime and cefuroxime were prepared, which solved the problem of isomerization transformation under basic conditions and achieved cebosporene The effective control and detection of the quality of furoxine ensures the purity and efficacy of the drug.
Patent Information
- Application Number
- CN202410965928.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-18
- Publication Date
- 2024-11-08
- Estimated Expiration
- 2044-07-18
AI Technical Summary
During the synthesis of cefuroxime, cefuroxime and cefuroxime are produced under alkaline conditions, which affects the efficacy of the drug. It is difficult for existing analytical methods to effectively separate and detect δ3-isomers, resulting in Difficult in quality control.
Siliconeization reaction with silicon under neutral conditions to protect the carboxylic group of cefurocinic acid, and then convert it into δ3-isomer protected by silicone ether under basic conditions, and after hydrolysis, it is used to carry out 1-bromoethyl acetate. The reaction was carried out to prepare the δ3-isomer of cefuroxime and double peak detection was performed using HPLC and other methods to ensure quality control.
Through targeted preparation and analysis methods, the δ3-isomers of cefuroxime acid and cefuroxime ester were successfully obtained, which avoids isomerization transformation under alkaline conditions, provides effective quality control measures, and ensures the purity of the drug and Medicinal effect.
Smart Images

Figure CN118908974A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of organic synthesis, and particularly relates to a method for preparing a δ3-isomer of cefuroxime acid and a δ3-isomer of cefuroxime axetil prepared by using the method. Background Art
[0002] Cefuroxime axetil is a prodrug of the second-generation cephalosporin antibiotic cefuroxime, which is decomposed into cefuroxime acid (API) in the body. Cefuroxime axetil is a well-characterized and effective antibacterial drug with a broad antibacterial spectrum and against a wide range of common pathogens. Its chemical synthesis is prepared by reacting cefuroxime acid with 1-bromoethyl acetate in the presence of a base:
[0003] Since a base is used in the reaction, the carbon at position 2 loses a proton under alkaline conditions, and the carbon at position 4 regains a proton, causing double bond migration. Both cefuroxime acid and cefuroxime axetil will produce their corresponding isomers. The mechanism is shown in the following formula:
[0004] Impurity research is the key to controlling the quality of chemical raw materials. The present invention provides a basis for the establishment of an analytical method by directional preparation of cefuroxime acid δ3-isomer and cefuroxime axetil δ3-isomer, which is of great significance for effectively controlling the quality of cefuroxime axetil. Summary of the invention
[0005] The purpose of the present invention is to provide a method for preparing a δ3-isomer of cefuroxime acid and a δ3-isomer of cefuroxime axetil prepared by the method.
[0006] In order to achieve the above object, the technical solution adopted by the present invention is:
[0007] A method for preparing a δ3-isomer of cefuroxime acid comprises the following steps: subjecting cefuroxime acid to a silyl etherification reaction with silicon under neutral conditions, isomerizing under alkaline conditions to obtain a silyl ether protected δ3-isomer thereof, and hydrolyzing the isomerized compound to remove the trimethylsilyl group to obtain the δ3-isomer of cefuroxime acid, also known as δ2-cefuroxime acid.
[0008] Furthermore, the silicon is N,O-bistrimethylsilylacetamide or N-trimethylsilylacetamide, the base is triethylamine or N,N-diisopropylethylamine, and the solvent is a halogenated hydrocarbon solvent, specifically dichloromethane or chloroform.
[0009] The invention discloses a method for preparing cefuroxime axetil δ3-isomer by using cefuroxime acid δ3-isomer. The prepared cefuroxime acid δ3-isomer is dissolved in a strongly polar aprotic solvent, and then a base and 1-bromoethyl acetate are added to react to obtain cefuroxime axetil δ3-isomer, also known as δ2-cefuroxime axetil. The product prepared by the invention is a diastereomeric mixture.
[0010] Furthermore, the strongly polar aprotic solvent is acetone, DMF, DMAc, or NMP, and the base is an organic base or an inorganic base, wherein the molar ratio of the base to the δ3-isomer of cefuroxime acid is 0.5 to 0.7:1.
[0011] Mechanism: In order to avoid the influence of salt formation of cefuroxime acid under the action of alkali on its conversion into δ3-isomer, the carboxyl group of cefuroxime acid is firstly protected by silyl ether, and then converted into its δ3-isomer protected by silyl ether under the action of alkali, and the silyl ether is removed by hydrolysis to obtain the cefuroxime acid δ3-isomer, and finally reacted with 1-bromoethyl acetate to obtain the δ3-isomer of cefuroxime axetil (diastereomeric mixture). The reaction is monitored by HPLC, and the liquid phase conditions are as follows: chromatographic column C18, 4.6*250mm, flow rate 1.5mL / min, mobile phase (20g of diammonium dihydrogen phosphate is diluted to 1000mL with water, mixed evenly with 600mL of methanol and then ultrasonically prepared for standby use), and the detection wavelength is 278nm; the specific reaction process is as follows:
[0012]
[0013] Experiments have confirmed that the δ3-isomer of cephalosporin drugs has no antibacterial activity. The δ3-isomer of cephalosporin drugs produced by double bond isomerization of the mother liquor during the production of cephalosporins seriously affects its efficacy. Therefore, when producing cefuroxime axetil, it is necessary to avoid isomerization into cefuroxime axetil δ3-isomer under alkaline conditions as much as possible to avoid affecting the quality of cefuroxime axetil. If the quality of cefuroxime axetil is to be strictly controlled, it is necessary to prepare the δ3-isomer of cefuroxime axetil in a targeted manner and provide a specific suitable analytical method for detection.
[0014] During the synthesis of cefuroxime axetil, due to the introduction of the chiral carbon of 1-bromoethyl acetate, it is a diastereomeric mixture:
[0015]
[0016] Due to the chiral carbon atom of the side chain, cefuroxime axetil is described as a double peak (isomer A and isomer B) in various pharmacopoeia documents at home and abroad. Therefore, the cefuroxime axetil δ3-isomer produced by double bond isomerization is also a diastereomer. When a suitable analytical method is used for detection, the liquid chromatography peak should also be a double peak. However, after trying the analytical method for cefuroxime axetil provided in the Chinese Pharmacopoeia document for detection, it was found that the cefuroxime axetil δ3-isomer peak was a single peak, and was not effectively separated from the cefuroxime axetil isomer A. There was even a case where the detected single peak of the cefuroxime axetil δ3-isomer overlapped with the cefuroxime axetil isomer A, as shown in the 2005 Chinese Pharmacopoeia. The United States Pharmacopoeia specifies that the cefuroxime axetil δ3-isomer is a diastereomer (related substance at RRT=1.2, description d).
[0017] The δ3-isomer of cefuroxime axetil prepared according to the method of the present invention is detected as a double peak (diastereomer mixture) using the analytical method provided in the present invention.
[0018] The invention has the advantages that: the invention provides a basis for establishing an analytical method by directional preparation of cefuroxime acid δ3-isomer and cefuroxime axetil δ3-isomer, which is of great significance for effectively controlling the quality of cefuroxime axetil. BRIEF DESCRIPTION OF THE DRAWINGS
[0019] Figure 1 The HPLC spectrum of the cefuroxime acid δ3-isomer prepared in the embodiment of the present invention.
[0020] Figure 2 It is the HPLC spectrum of the δ3-isomer of cefuroxime axetil (diastereomeric mixture) prepared in the embodiment of the present invention.
[0021] Figure 3 It is the δ3-isomer of cefuroxime acid prepared in the embodiment of the present invention. 1 H NMR (400 MHz, DMSO-d) spectrum.
[0022] Figure 4 It is the δ3-isomer of cefuroxime axetil prepared in the embodiment of the present invention. 1 HNMR (400 MHz, DMSO-d) spectrum.
[0023] Figure 5 It is the δ3-isomer of cefuroxime acid prepared in the embodiment of the present invention. 13 C NMR (400 MHz, DMSO-d) spectrum.
[0024] Figure 6 It is the δ3-isomer of cefuroxime axetil prepared in the embodiment of the present invention. 13 CNMR (400MHz, DMSO-d) spectrum. DETAILED DESCRIPTION
[0025] Example
[0026] A method for preparing cefuroxime acid δ3-isomer and cefuroxime axetil δ3-isomer comprises the following steps:
[0027] 1. Synthesis of cefuroxime acid δ3-isomer by silane etherification-isomerization-hydrolysis reaction:
[0028]
[0029] In a glass bottle equipped with a stirrer and a thermometer, 200 mL of dichloromethane was added at room temperature, and 15 g of cefuroxime acid was added and stirred to obtain a white turbid suspension. 9.8 g of N-trimethylsilylacetamide was added dropwise under an ice-water bath. After the addition was completed, the temperature was raised to 20 to 30° C. and stirred for reaction for 1 hour. The reaction liquid turned into an orange-red transparent clear solution. The liquid phase detection showed that the residual cefuroxime acid was 5.4%. 11.5 g of triethylamine was added dropwise under an ice-water bath. After the addition was completed, the isomerization reaction was carried out at room temperature for 20 hours. The reaction liquid turned into an orange-red color. The residual cefuroxime acid in the reaction liquid was 4% by liquid phase detection. The cefuroxime under silyl ether protection Acid δ3-isomer 84%, add 100mL of purified water, stir and hydrolyze at room temperature for 30min, separate the layers, discard the organic layer, take the water layer, wash the water layer with 50mL of dichloromethane, separate the layers, add 1g of activated carbon to the water layer and decolorize it for 2h, filter the filtrate and add 5% dilute hydrochloric acid to adjust the pH of the reaction solution to about 3.0, stir and crystallize, continue stirring for 1h after the solid is precipitated, filter, wash the filter cake with 50mL of water, and finally rinse with 100mL of 25% acetone aqueous solution, and dry the filter cake at 50℃ with air blast to obtain 9.7g of cefuroxime acid δ3-isomer, with a liquid phase detection purity greater than 96%.
[0030] 2. Synthesis of cefuroxime axetil δ3-isomer (diastereomeric mixture) by condensation reaction:
[0031]
[0032] Add 10 g of cefuroxime acid δ3-isomer to a glass bottle equipped with a stirrer and a thermometer, add 200 mL of acetone to dissolve it, cool it to 10°C, add 3.3 g of powdered potassium carbonate and 4.8 g of ethyl 1-bromoethyl acetate, control the internal temperature at 5 to 10°C and stir to react for 3 hours. The liquid phase detects that 5.3% of cefuroxime acid δ3-isomer remains. Recover acetone under reduced pressure below 15°C. After recovery, add 200 mL of ethyl acetate and 80 mL of water to the residual liquid, stir to make the reaction system clear, and add saturated and sodium bicarbonate aqueous solution to adjust the pH of the reaction solution to about 7, separate the layers, discard the aqueous layer, wash the organic layer twice with 100 mL of 10% NaCl aqueous solution, and after separation, recover most of the ethyl acetate under reduced pressure in the organic layer to obtain an oily substance, add 150 mL of isopropyl ether, grind and stir at room temperature for 3 h until a solid precipitates, filter, and dry in vacuo at 50 ° C for 24 h to obtain 5.2 g of light yellow solid cefuroxime axetil δ3-isomer (diastereomeric mixture), and the purity detected by liquid phase is 94.1% (total area of diastereomers).
Claims
1. A method for preparing cefuroxime acid δ3-isomer, characterized in that: The following steps are involved: Cefuroxime acid is subjected to a silyl etherification reaction with silicon under neutral conditions, and then isomerized under alkaline conditions to obtain its silyl ether protected delta 3-isomer, and the isomerized compound is hydrolyzed to remove the trimethylsilyl group to obtain the cefuroxime acid delta 3-isomer.
2. The method for preparing the cefuroxime acid δ3-isomer according to claim 1, characterized in that: The silicon is N,O-bistrimethylsilylacetamide or N-trimethylsilylacetamide, the base is triethylamine or N,N-diisopropylethylamine, and the solvent is a halogenated hydrocarbon solvent, specifically dichloromethane or chloroform.
3. A method for preparing cefuroxime axetil δ3-isomer using the cefuroxime acid δ3-isomer prepared according to claim 2, characterized in that: The prepared cefuroxime acid δ3-isomer is dissolved in a strong polar aprotic solvent, and then a base and 1-bromoethyl acetate are added to react to obtain cefuroxime axetil δ3-isomer.
4. The method according to claim 3, characterized in that: The strongly polar aprotic solvent is acetone, DMF, DMAc, or NMP, and the base is an organic base or an inorganic base, wherein the molar ratio of the base to the cefuroxime acid δ3-isomer is 0.5 to 0.7:1.
Citation Information
Patent Citations
Preparation method of cefalonium
CN104725403A
Preparation methods of Cefditoren acid delta 3 isomer and cefditoren pivoxil delta 3 isomer
CN110372727A
Cefuroxime axetil-3-ene isomer preparation method
CN110590811A
Preparation method of cefditoren pivoxil [delta]3 isomer
CN111233894A
